In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American ...

Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...

The guidelines support use of PPIs, dietary therapy, and biologics for EoE, and stress the importance of addressing both the ...

Medically reviewed by Qin Rao, MD Eosinophilic esophagitis (EoE) is a chronic (long-term) condition affecting the esophagus, ...

An elemental diet is a medical protocol that replaces food and drinks with liquid formula for people with serious GI ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 35.6% in the past six months compared with the industry’s decline ...

Esophageal dilation is a treatment to help stretch, or dilate, abnormal narrowings found in the esophagus. These narrowings are called strictures and can occur from a variety of health problems. They ...

The ACG developed 19 recommendations related to the diagnosis and management of eosinophilic esophagitis. Guideline panel members also considered pediatric-specific concerns such as feeding ...

Vieira et al. 4 explored how different pathologist expertise may influence the identification of the eosinophilic infiltration and additional histological changes included in the eosinophilic ...

CALY-002 is under clinical development by Novartis and currently in Phase I for Eosinophilic Esophagitis. According to GlobalData, Phase I drugs for Eosinophilic Esophagitis have an 86% phase ...

A recent novel study published in the New England Journal of Medicine found that Depemokimab can reduce asthma exacerbations in patients with the eosinophilic phenotype. Improperly controlled asthma ...

The FDA approved the use of dupilumab (Dupixent; Regeneron, Sanofi) for treating eosinophilic esophagitis in children ... the American Academy of Allergy, Asthma & Immunology Annual Meeting.